Pfizer-BioNTech to Seek FDA EUA for COVID-19 Vaccine That Proves 95% Effective in Final Study
Pfizer Inc. (New York, NY, USA) and Biopharmaceutical New Technologies (BioNTech Mainz, Germany) have concluded the Phase 3 study of their COVID-19 vaccine candidate, meeting all primary efficacy endpoints. More...19 Nov 2020
Chinese Firm Sinovac Biotech’s COVID-19 Vaccine Triggers Quick Immune Response in Mid-Stage Trials
Sinovac Biotech Ltd.’s (Beijing, China) experimental COVID-19 vaccine CoronaVac triggered a quick immune response in preliminary trial results, although the level of antibodies produced was found to be lower in recovered COVID-19 patients. More...19 Nov 2020
Mobile Mini-Laboratory System Identifies SARS-CoV-2 Virus in 40 Minutes and Conducts 60 Tests per Day
A new mini-laboratory system can identify the SARS-CoV-2 virus within roughly 40 minutes and makes it possible to conduct up to 60 tests a day right on the spot where samples are taken. More...18 Nov 2020
Teleradiologists Highly Accurate at Diagnosing COVID-19 on Chest CTs
A new study by a group of French radiologists has found that teleradiologists can be highly accurate in diagnosing COVID-19 from chest computed tomography (CT) scans and their performance can be on par with senior radiologists. More...18 Nov 2020
Gold Member
12-Channel ECG
CM1200B
New
Gold Member
X-Ray QA Meter
T3 AD Pro
New
Monitor Cart
Tryten S5
New
Digital Radiographic System
OMNERA 300M
In Other News
Hospitalized COVID-19 Patients Receiving Inhaled Nebulized Interferon Beta-1a Show Greater Improvement
ELITechGroup Submits SARS-CoV-2 Plus ELITe MGB Assay for FDA Emergency Use Authorization
Eli Lilly and Samsung Biologics Sign Long-Term Production Agreement for COVID-19 Antibody Therapies
Moderna’s COVID-19 Vaccine Shows Nearly 95% Effectiveness in Phase 3 Study
Primate Study Reveals SARS-CoV-2 Immunosuppressive Effects for Development of COVID-19 Treatments and Vaccines
New Drugs Under Development to Treat Aggressive Prostate Cancer Could Fight COVID-19
Chest X-Rays of COVID-19 Patients Have High Likelihood of Predicting Positive RT-PCR Test Results
Overuse of Computed Tomography (CT) on COVID-19 Patients Raises Concerns
New COVID-19 Vaccination Strategy Suggests Targeting Potential Superspreaders First
Promising New Compounds Could Accelerate Efforts to Develop Anti-Viral Drugs to Fight COVID-19
Virusight Diagnostic’s AI Solution for COVID-19 1-Second Test Demonstrates Excellent Correlation to PCR
Scientists Identify Eight Genetic "Super-Variants" that Increase Risk of Dying From COVID-19
COVID-19 Immunity Lasts Six Months or More, Reveals New SARS-CoV-2 Antibody Analysis
Moderna Accumulates Sufficient COVID-19 Vaccine Trial Data for Early Readout by November End
New Virtual Reality (VR) Technique to Help Develop Drugs for Treatment of COVID-19
PerkinElmer SARS-CoV-2 RT-PCR Assay Receives CE Mark for Saliva and Sample Pooling
Web-Based Algorithms Applied to Low-Dose CTs Could Automate Detection of COVID-19
New COVID-19 Test That Identifies T-Cell Signature Better at Detecting Past Coronavirus Infection
RNA Structures of SARS-CoV-2 Reveal Potential Drug Targets
Medicago’s COVID-19 Vaccine Combined with GSK’s Vaccine Booster Triggers Immune Response in All Study Participants
Korean Firm Celltrion’s Anti-COVID-19 Monoclonal Antibody Treatment Kills SARS-CoV-2 Virus Within 4-5 Days
Co-Diagnostics’ CoPrimers Platform Demonstrates Effectiveness in COVID-19 Saliva PCR Tests Without Sample Extraction
Eli Lilly's Investigational Monoclonal Antibody Therapy Bamlanivimab Granted FDA EUA for Treatment of COVID-19
